U.S. In-Vitro Diagnostics Market Set to Surge to $56 Billion by 2030 Driven by Innovation and Disease Testing Demand
• U.S. in-vitro diagnostics market projected to reach $56.52 billion by 2030, driven by technological innovations and need for efficient diagnosis • Market is witnessing surge in demand due to automated IVD structures offering improved precision and efficiency • Escalating prevalence of chronic and infectious diseases propelling adoption of in-vitro diagnostic testing • Aging population and need for health monitoring for age-related conditions like cardiovascular disease and diabetes bolstering market growth • Recent strategic collaborations and product launches shaping industry landscape, like Atila Biosystems and Stilla Technologies distributing co-labeled digital PCR equipment